Synergistic Gastrointestinal Therapeutic Systems

A novel, integrated system combining implantable and non-invasive stimulators with AI, IoT, blockchain, and advanced materials for personalized, data-driven gastrointestinal therapeutics.

The original patent addressed gastrointestinal therapeutics through implantable and non-invasive stimulators. However, these systems lacked real-time data analysis, secure data storage, and personalized treatment planning. The new inventive concept integrates distinct technologies to create a more powerful, synergistic system that addresses these limitations.

The system comprises a miniaturized implant or non-invasive stimulator integrated with AI-powered diagnostic modules for real-time analysis of GI tract activities. IoT sensors enable real-time monitoring of patient physiological signals, while blockchain-based data storage ensures secure patient data management. The system also incorporates novel biocompatible materials, data analytics modules, and AI-driven predictive analytics for personalized treatment planning. The wearable device tracks gut-brain axis activities, and a mobile app enables patient engagement and data tracking.

The new claims introduce the integration of AI, IoT, blockchain, and advanced materials with implantable and non-invasive stimulators, providing a synergistic system that offers real-time data analysis, secure data storage, and personalized treatment planning. This integration is new and non-obvious compared to the original patent.

Alternative embodiments may include varying the type of AI algorithm used, incorporating different IoT sensors, or utilizing alternative blockchain-based data storage solutions. Variations may also include integrating the system with other healthcare technologies, such as telemedicine platforms or electronic health records.

The inventive concept has significant commercial potential in the gastrointestinal therapeutics market, with applications in treating gastrointestinal dysmotility, obesity, and other related disorders. The system's data-driven approach and personalized treatment planning capabilities position it for success in the growing digital health market.